HomePentostatinPentostatin + Nelarabine

Does Pentostatin Interact with Nelarabine?

Pentostatin and Nelarabine have a contraindicated drug interaction according to U.S. FDA drug labeling data. Administration of nelarabine in combination with pentostatin (an adenosine deaminase inhibitor) is not recommended. The mechanism involves adenosine deaminase inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Pentostatin Class
Nucleoside Metabolic Inhibitor
Nelarabine Class
Nucleoside Metabolic Inhibitor
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Pentostatin and Nelarabine occurs because adenosine deaminase inhibition. Clinically, this means administration of nelarabine in combination with pentostatin (an adenosine deaminase inhibitor) is not recommended. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Pentostatin and your doctor is considering prescribing Nelarabine (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Pentostatin(Nipent)+💊 Nelarabine(Arranon)

Severity & Interaction Details

contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Nucleoside Metabolic Inhibitor
Drug B class
Nucleoside Metabolic Inhibitor
Source
NLP:nelarabine

What this means in plain English

Administration of nelarabine in combination with pentostatin (an adenosine deaminase inhibitor) is not recommended.

About Pentostatin and Nelarabine

Pentostatin and Nelarabine both belong to the Nucleoside Metabolic Inhibitor class. You may recognize them by the brand names Nipent and Arranon. Both medications are given by intravenous (IV) infusion. Both Pentostatin and Nelarabine carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Adenosine deaminase inhibition"

📖 Source: NLP:nelarabine

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Pentostatin and Nelarabine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.